<?xml version='1.0' encoding='UTF-8'?><!DOCTYPE collection SYSTEM 'BioC.dtd'>
<collection>
  <source>SourceData</source>
  <date>00000000</date>
  <key>sourcedata.key</key>
  <document>
    <id>4967947 Figure_1-B</id>
    <infon key="sourcedata_document">2033</infon>
    <infon key="doi">10.15252/emmm.201505944</infon>
    <infon key="pmc_id">4967947</infon>
    <infon key="figure">Figure 1-B</infon>
    <infon key="sourcedata_figure_dir">Figure_1-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Time constants of decay, &#964;decay, of the STC isolated pharmacologically in WT and FHM2 KI mice. Top, superimposed representative traces of the inward current evoked in an astrocyte (held at -90 mV) by a single pulse stimulation (indicated by the arrow) in a WT slice, before (trace a) and after (trace b) application of a saturating concentration of the GluT inhibitor TFB-TBOA (TBOA). The STC was obtained by subtracting the residual current remaining in the presence of TBOA from the total inward current (trace a-b); the decay of the STC was best fitted by a single exponential function with &#964;decay = 6.53 ms (in red). The bar plot shows the average values of &#964;decay of the STC isolated pharmacologically in cortical slices (n=13) from P22-23 WT (N=7) and KI mice (n=9; N=3). STC &#964;decay is 17% higher in KI compared to WT astrocytes (unpaired t-test: P = 0.003). Hereafter, n indicates the number of slices and N indicates the number of mice.</text>
    </passage>
  </document>
  <document>
    <id>4967947 Figure_1-C</id>
    <infon key="sourcedata_document">2033</infon>
    <infon key="doi">10.15252/emmm.201505944</infon>
    <infon key="pmc_id">4967947</infon>
    <infon key="figure">Figure 1-C</infon>
    <infon key="sourcedata_figure_dir">Figure_1-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) &#964;decay of the STC isolated using an exponential waveform approximating the average TBOA-insensitive current in WT and KI mice. Top trace, average normalized TBOA-insensitive current obtained by pooling the normalized TBOA-insensitive currents recorded in 16 WT and KI cells. This current was best fitted by an exponentially rising function (1-exp (-t/&#964;rise)) with &#964;rise= 2.35 ms (in green). The STC was obtained by subtracting from the total current elicited in the astrocyte (a: same representative trace as in (B)) the exponential function A(1-exp (-t/&#964;rise)) with &#964;rise = 2.35 ms and A equal to the maximal current measured in the astrocyte at about 60 ms after stimulation (trace c); the decay of the STC (trace a-c) was best fitted by a single exponential function with &#964;decay = 6.49 ms (in red). The bar plot shows the average values of &#964;decay of the STC isolated as shown in the top panel in cortical slices from P22-23 WT (n = 28; N=11) and KI mice (n = 27; N=9). STC &#964;decay is 21% higher in KI compared to WT astrocytes (unpaired t-test: P &lt; 0.0001).</text>
    </passage>
  </document>
  <document>
    <id>4967947 Figure_2-A</id>
    <infon key="sourcedata_document">2033</infon>
    <infon key="doi">10.15252/emmm.201505944</infon>
    <infon key="pmc_id">4967947</infon>
    <infon key="figure">Figure 2-A</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Isolation of the STC elicited by the last pulse of a high-frequency train of action potentials. Left: superimposed representative traces of the inward current evoked in an astrocyte (held at -90 mV) by extracellular stimulation with a train of 10 pulses (trace a: black) and a train of 9 pulses (trace b: brown) at 50 Hz in a WT cortical slice. The inward current elicited by the 10th pulse was obtained by subtracting the current elicited by 9 pulses from that elicited by 10 pulses (trace a-b). Right: The STC elicited by the 10th pulse (trace a-b-c) was obtained by subtracting the exponential function that simulates the TBOA-insensitive current elicited by a single pulse (trace c, obtained as in Figure 1C) to the 10-9 pulses difference current (trace a-b). The decay of the STC elicited by the 10th pulse was best fitted by a single exponential function with &#964;decay = 8.04 ms (in red).</text>
    </passage>
  </document>
  <document>
    <id>4967947 Figure_2-B</id>
    <infon key="sourcedata_document">2033</infon>
    <infon key="doi">10.15252/emmm.201505944</infon>
    <infon key="pmc_id">4967947</infon>
    <infon key="figure">Figure 2-B</infon>
    <infon key="sourcedata_figure_dir">Figure_2-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) &#964;decay of the STC elicited by the 10th pulse of 50 Hz (&#964;10 (50 Hz), left panel) and 100 Hz (&#964;10 (100 Hz), right panel) trains in layer 1 astrocytes in acute cortical slices from P22-23 WT (n = 23; N=10 for 50 Hz; n = 18; N=8 for 100 Hz) and KI (n = 21; N=9 for 50 Hz and n = 14; N=7 for 100 Hz) mice. The STC elicited by the 10th pulse was obtained as described in (A). STC &#964;10 (50 Hz) and &#964;10 (100 Hz) are 30% and 37% higher in KI compared to WT mice, respectively (unpaired t-test: P &lt; 0.0001 in both cases).</text>
    </passage>
  </document>
  <document>
    <id>4967947 Figure_3-A-B</id>
    <infon key="sourcedata_document">2033</infon>
    <infon key="doi">10.15252/emmm.201505944</infon>
    <infon key="pmc_id">4967947</infon>
    <infon key="figure">Figure 3-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Simultaneous visualization of GLT-1a+ (green) and VGLUT1+ puncta (red) in first somatic sensory cortex (SI) of a WT and a KI mouse (P35). Arrows point to some GLT-1a+ puncta overlaying with VGLUT1+ puncta (i.e., GLT-1a/VGLUT1 related puncta); framed regions (enlarged below) are examples of GLT-1a/VGLUT1 related puncta (arrowheads). All microscopic fields are from layers II/III. Scale bars: 3.5 &#181;m for left and right panels and 1 &#181;m for enlarged framed areas. (B) Percentage and size of GLT-1a+ puncta overlaying with VGLUT1 in P35 WT and KI mice. Left, percentage of GLT-1a+ puncta overlaying with VGLUT1 is comparable in WT and KI mice (data were obtained from 14 and 18 fields of 20 &#181;m x 20 &#181;m from 2 WT and 2 KI mice (4 sections/animal), respectively) (unpaired t-test: P = 0.52). Right, size of GLT-1a/VGLUT1 related puncta is 19 % reduced in KI mice (169 GLT-1a+ puncta analyzed from 2 mice) compared to WT (174 GLT-1a+ puncta analyzed from 2 mice) (Mann-Withney U test: P = 0.016).</text>
    </passage>
  </document>
  <document>
    <id>4967947 Figure_4-A</id>
    <infon key="sourcedata_document">2033</infon>
    <infon key="doi">10.15252/emmm.201505944</infon>
    <infon key="pmc_id">4967947</infon>
    <infon key="figure">Figure 4-A</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Distribution of GLT-1agold particles in astrocytic processes contacting asymmetric synapses (perisynaptic astrocytic processes: PAP) in SI of 5 WT and 5 KI (2 male, 3 female) mice (P34-35). In cortical PAP of KI mice the density (particles/&#181;m2) of total and membrane-associated gold particles (arrowheads) are reduced compared to WT mice, whereas the density of cytoplasmicgold particles (arrows) is comparable to that in WT (cf Table I for numerical values and statistics).</text>
    </passage>
  </document>
  <document>
    <id>4967947 Figure_4-B</id>
    <infon key="sourcedata_document">2033</infon>
    <infon key="doi">10.15252/emmm.201505944</infon>
    <infon key="pmc_id">4967947</infon>
    <infon key="figure">Figure 4-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Distribution of GLT-1agold particles in excitatory axon terminals forming asymmetric synaptic contact (AxT) in SI of P34-35 WT and KI mice. In cortical AxT of KI and WT mice, GLT-1a density is comparable (arrowheads: membrane-associated gold particles; arrows: cytoplasmicgold particles) (cf Table I).</text>
    </passage>
  </document>
  <document>
    <id>4967947 Figure_5-A</id>
    <infon key="sourcedata_document">2033</infon>
    <infon key="doi">10.15252/emmm.201505944</infon>
    <infon key="pmc_id">4967947</infon>
    <infon key="figure">Figure 5-A</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A</infon>
    <passage>
      <offset>0</offset>
      <text>Left, superimposed representative traces of the normalized inward current evoked in a WT (black trace) and a KI corticalastrocyte (blue trace) by extracellular stimulation with a train of 10 pulses at 50 Hz in cortical slices. The inset shows in an expanded time scale the portion of the traces indicated by the dotted line. The slowly decaying current (&#964;decay = 2.00 s and 3.04 s for the WT and KI trace, respectively) is largely a [K+]e-dependent K+current (IK) whose decay kinetics provide a measure of the rate of K+ clearance by astrocytes (see text). Right, time constant of decay of IK elicited by trains of 10 pulses at 50 Hz in corticalastrocytes from P22-23 WT (n = 21; N=12) and KI mice (n = 20; N=8). IK &#964;decay is 22% higher in KI compared to WT astrocytes (unpaired t-test: P = 0.001).</text>
    </passage>
  </document>
  <document>
    <id>4967947 Figure_6-A</id>
    <infon key="sourcedata_document">2033</infon>
    <infon key="doi">10.15252/emmm.201505944</infon>
    <infon key="pmc_id">4967947</infon>
    <infon key="figure">Figure 6-A</infon>
    <infon key="sourcedata_figure_dir">Figure_6-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Images of a cortical slice before (t = 0) and after (t = 15.6 s) pressure ejection of a high KCl pulse that elicits a CSD (top panels), showing that the propagating CSD is associated with a change in light transmittance. Scale bar: 500 &#181;m. The traces below show representative changes in intrinsic optical signal (IOS) relative to background measured in a WT and a KI cortical slice during CSD propagation at increasing times and distances from the KCl puff, as indicated in color code in the right image on the top. The velocity of CSD propagation, obtained from the rate of horizontal spread of the change in IOS, in these two representative WT and KI slices is 3.11 and 4.14 mm/min, respectively. (B) Stimulation threshold for CSD induction (CSD threshold) and rate of CSD propagation (CSD velocity) in WT (n = 24; N=3) and KI (n = 27; N=8) cortical slices from P22-23 mice. CSD threshold is expressed as duration of the first KCl pulse eliciting a CSD. CSD threshold is 28% lower (Mann Whitney U test, P &lt; 0.0001) and CSD velocity 21% higher (unpaired t-test: P&lt; 0.0001) in KI compared to WT mice.</text>
    </passage>
  </document>
  <document>
    <id>4967947 Figure_7-A</id>
    <infon key="sourcedata_document">2033</infon>
    <infon key="doi">10.15252/emmm.201505944</infon>
    <infon key="pmc_id">4967947</infon>
    <infon key="figure">Figure 7-A</infon>
    <infon key="sourcedata_figure_dir">Figure_7-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Western blottings of GLT-1a in cortical crude synaptic membranes of P39 WT mice following Cef treatment for 8 days. GLT-1a levels are significantly increased in mice treated with Cef (Cef WT, N = 4) compared to control saline-injected mice (Ctr WT, N = 4) (Mann-Withney U test: P = 0.028).</text>
    </passage>
  </document>
  <document>
    <id>4967947 Figure_7-B</id>
    <infon key="sourcedata_document">2033</infon>
    <infon key="doi">10.15252/emmm.201505944</infon>
    <infon key="pmc_id">4967947</infon>
    <infon key="figure">Figure 7-B</infon>
    <infon key="sourcedata_figure_dir">Figure_7-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Visualization of GLT-1a+ puncta (green) and VGLUT1+ puncta (red) in sections from SI of P45-46 WT mice that were treated with saline (Ctr WT) or Cef (Cef WT). Arrows point to some GLT-1a/VGLUT1 related puncta. Framed regions (enlarged below) are examples of GLT-1a/VGLUT1 related puncta (arrowheads). Right, Cef treatment increased significantly the size of GLT-1a+ puncta overlaying VGLUT1 (142 and 186 GLT-1a+ puncta analyzed from 4 Ctr WT and 4 Cef WT mice, respectively; 3 sections/animal) (Mann-Withney U test: P &lt; 0.0001). All microscopic fields are from layers II/III. Scale bars: 3.5 &#181;m for left and right panels and 1 &#181;m for enlarged framed areas.</text>
    </passage>
  </document>
  <document>
    <id>4967947 Figure_7-C</id>
    <infon key="sourcedata_document">2033</infon>
    <infon key="doi">10.15252/emmm.201505944</infon>
    <infon key="pmc_id">4967947</infon>
    <infon key="figure">Figure 7-C</infon>
    <infon key="sourcedata_figure_dir">Figure_7-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) CSD threshold and CSD velocity in cortical slices from P30-33 KI mice that were injected with saline (Ctr KI, n = 38; N=7) or Cef (Cef KI, n = 31; N=6). CSD threshold is 12% higher (Mann-Withney U test: P = 0.02) in Cef-treated compared to saline-treated KI mice. CSD velocity is not altered by Cef treatment (P = 0.90).</text>
    </passage>
  </document>
  <document>
    <id>4967947 Figure_8-A</id>
    <infon key="sourcedata_document">2033</infon>
    <infon key="doi">10.15252/emmm.201505944</infon>
    <infon key="pmc_id">4967947</infon>
    <infon key="figure">Figure 8-A</infon>
    <infon key="sourcedata_figure_dir">Figure_8-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Distribution of GLT-1agold particles in PAP of saline-injected (Ctr KI, N=4) and Cef-treated KI mice (Cef KI, N=4) (P45-46). Cef treatment does not modify the density of total, cytoplasmic (arrows) and membrane-associated (arrowheads) gold particles in PAP of KI mice (cf Table II).</text>
    </passage>
  </document>
  <document>
    <id>4967947 Figure_8-B</id>
    <infon key="sourcedata_document">2033</infon>
    <infon key="doi">10.15252/emmm.201505944</infon>
    <infon key="pmc_id">4967947</infon>
    <infon key="figure">Figure 8-B</infon>
    <infon key="sourcedata_figure_dir">Figure_8-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Distribution of GLT-1a gold particles in AxT in SI of Ctr KI and Cef KI KI mice. The density of the membrane-associated gold particles (arrowheads) is increased in Cef-treated KI mice (cf Table II).</text>
    </passage>
  </document>
  <document>
    <id>4967947 Figure_8-C</id>
    <infon key="sourcedata_document">2033</infon>
    <infon key="doi">10.15252/emmm.201505944</infon>
    <infon key="pmc_id">4967947</infon>
    <infon key="figure">Figure 8-C</infon>
    <infon key="sourcedata_figure_dir">Figure_8-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Western blottings of GLT-1a in cortical crude synaptic membranes of P39 KI mice following Cef treatment. GLT-1a levels are similar in Cef-treated (Cef KI, N=4) and and saline-injected (Ctr KI, N=4) (Mann-Withney U test: P = 0.83).</text>
    </passage>
  </document>
  <document>
    <id>4967947 Figure_8-D</id>
    <infon key="sourcedata_document">2033</infon>
    <infon key="doi">10.15252/emmm.201505944</infon>
    <infon key="pmc_id">4967947</infon>
    <infon key="figure">Figure 8-D</infon>
    <infon key="sourcedata_figure_dir">Figure_8-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Visualization of GLT-1a+ puncta (green) and VGLUT1+ puncta (red) in KI mice that received saline (Ctr KI) and in Cef-treated KI mice (Cef KI) (P45-46). Arrows point to some GLT-1a/VGLUT1 related puncta; framed regions are examples of GLT-1a/VGLUT1 related puncta (arrowheads). Right, Cef treatment does not increase the size of GLT-1a+ puncta overlaying with VGLUT1 (160 and 175 GLT-1a+ puncta analyzed from the same 4 Ctr KI and 4 Cef KI used for post-embedding electron microscopy analysis; 3 sections/animal) (Mann-Withney U test: P = 0.31). Scale bar: 3.5 &#181;m for left and right panels and 1 &#181;m for enlarged framed areas. All microscopic fields are from layers II/III.</text>
    </passage>
  </document>
  <document>
    <id>4967947 Figure_9-A</id>
    <infon key="sourcedata_document">2033</infon>
    <infon key="doi">10.15252/emmm.201505944</infon>
    <infon key="pmc_id">4967947</infon>
    <infon key="figure">Figure 9-A</infon>
    <infon key="sourcedata_figure_dir">Figure_9-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) &#964;decay of the STC evoked by single pulse stimulation in layer 1 astrocytes in acute cortical slices from P22-23 WT mice before (Ctr WT) and after application of 2.5 &#181;M DL-TBOA (TBOA 2.5) (n = 4; N=2) (right panel). The traces on the left are the corresponding average normalized STCs, isolated as in Figure 1C. The STC &#964;decay in TBOA 2.5 is 32 &#177; 2 % higher than in Ctr WT (paired t-test: P = 0.002). The left top panel shows the time course of &#964;decay of the transient component (due to the STC) of the current recorded in an astrocyte during a representative experiment in which TBOA 2.5 was applied at the time indicated by the horizontal bar. The steady-state effect was reached within 10-15 minutes from the beginning of the drug perfusion.</text>
    </passage>
  </document>
  <document>
    <id>4967947 Figure_9-B</id>
    <infon key="sourcedata_document">2033</infon>
    <infon key="doi">10.15252/emmm.201505944</infon>
    <infon key="pmc_id">4967947</infon>
    <infon key="figure">Figure 9-B</infon>
    <infon key="sourcedata_figure_dir">Figure_9-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) CSD threshold and velocity measured in cortical slices from P22-23 WT mice after perfusion for 20 minutes with extracellular solution without (Ctr WT: n = 23; N = 15) and with 2.5 &#181;M DL-TBOA (TBOA 2.5: n = 25; N = 8). CSD threshold in TBOA 2.5 is 36 % lower than in Ctr WT (Mann-Withney U test test: P &lt; 0.0001) and CSD velocity is 20% higher (unpaired t-test: P &lt; 0.0001).</text>
    </passage>
  </document>
  <document>
    <id>4967947 Figure_9-C</id>
    <infon key="sourcedata_document">2033</infon>
    <infon key="doi">10.15252/emmm.201505944</infon>
    <infon key="pmc_id">4967947</infon>
    <infon key="figure">Figure 9-C</infon>
    <infon key="sourcedata_figure_dir">Figure_9-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) &#964;decay of the STC evoked by single pulse stimulation in layer 1 astrocytes in acute cortical slices from P22-23 WT mice before (Ctr WT) and after application of 1.5 &#181;M DL-TBOA (TBOA 1.5) (n = 4; N=4). The STC &#964;decay in TBOA 1.5 is 22 &#177; 3 % higher than in Ctr WT (paired t-test: P = 0.004).</text>
    </passage>
  </document>
  <document>
    <id>4967947 Figure_9-D</id>
    <infon key="sourcedata_document">2033</infon>
    <infon key="doi">10.15252/emmm.201505944</infon>
    <infon key="pmc_id">4967947</infon>
    <infon key="figure">Figure 9-D</infon>
    <infon key="sourcedata_figure_dir">Figure_9-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) CSD threshold and velocity measured in cortical slices from P22-23 WT mice after perfusion for 20 minutes with extracellular solution without (Ctr WT: n = 23; N = 15) and with 1.5 &#181;M DL-TBOA (TBOA 1.5: n = 18; N = 6). CSD threshold in TBOA 1.5 is 23 % lower than in Ctr WT (Mann-Withney U test test: P &lt; 0.0001) and CSD velocity is 13 % higher (unpaired t-test: P = 0.003).</text>
    </passage>
  </document>
</collection>
